There were 2,443 press releases posted in the last 24 hours and 440,388 in the last 365 days.

Nuance to Participate in Upcoming Investor Conferences

BURLINGTON, Mass., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Nuance Communications, Inc. (NASDAQ: NUAN) today announced that management will present at the following upcoming investor conferences:

  • SVB Leerink 9th Annual Global Healthcare Conference
    Lotte New York Palace Hotel
    February 26, 2020 at 10:30 AM ET
  • Oppenheimer 30th Annual Healthcare Conference
    The Intercontinental New York Barclay Hotel
    March 17, 2020 at 10:55 AM ET

A live webcast and replay of each presentation will be available at http://investor.nuance.com.

About Nuance Communications, Inc.
Nuance Communications (NASDAQ: NUAN) is the pioneer and leader in conversational AI innovations that bring intelligence to everyday work and life. The company delivers solutions that understand, analyze, and respond to people – amplifying human intelligence to increase productivity and security. With decades of domain and AI expertise, Nuance works with thousands of organizations globally across healthcare, financial services, telecommunications, government, and retail – to empower a smarter, more connected world. For more information, please visit www.nuance.com.

Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.

Contact Information

For Investors
Tracy Krumme
SVP, Investor Relations
Nuance Communications, Inc.
781-565-4334
tracy.krumme@nuance.com

Primary Logo

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.